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DNA replication control is a key process in maintaining genomic integrity. Monitoring DNA
replication initiation is particularly important as it needs to be coordinated with other
cellular events and should occur only once per cell cycle. Crucial players in the initiation
of DNA replication are the ORC protein complex, marking the origin of replication, and
the Cdt1 and Cdc6 proteins, that license these origins to replicate by recruiting the
MCM2-7 helicase. To accurately achieve its functions, Cdt1 is tightly regulated. Cdt1 levels
are high from metaphase and during G1 and low in S/G2 phases of the cell cycle. This con-
trol is achieved, among other processes, by ubiquitination and proteasomal degradation. In
an overexpression screen for Cdt1 deubiquitinating enzymes, we isolated USP37, to date
the first ubiquitin hydrolase controlling Cdt1. USP37 overexpression stabilizes Cdt1, most
likely a phosphorylated form of the protein. In contrast, USP37 knock down destabilizes
Cdt1, predominantly during G1 and G1/S phases of the cell cycle. USP37 interacts with
Cdt1 and is able to de-ubiquitinate Cdt1 in vivo and, USP37 is able to regulate the loading
of MCM complexes onto the chromatin. In addition, downregulation of USP37 reduces
DNA replication fork speed. Taken together, here we show that the deubiquitinase
USP37 plays an important role in the regulation of DNA replication. Whether this is
achieved via Cdt1, a central protein in this process, which we have shown to be stabilized
by USP37, or via additional factors, remains to be tested.
ª 2016 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights
reserved.e.
; fax: þ34 922647112.
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M O L E C U L A R O N C O L O G Y 1 0 ( 2 0 1 6 ) 1 1 9 6e1 2 0 6 11971. Introduction the SCFeSkp2, the CRL4-Cdt2 E3 ubiquitin ligase complexesReplicating the genome is an essential process for living organ-
isms. DNA replication needs to be tightly regulated and moni-
tored in order to preserve cellular genomic stability. First,
because the genome needs to be replicated only once per cell
cycle to avoid differences in genome content between the
mother and daughter cells and second, because while DNA
synthesis occurs, the genome is particularly vulnerable to
damage and errors. In eukaryotic cells, complex mechanisms
control and monitor DNA replication. A critical regulated step
to avoid DNA replication associated instability occurs at the
initiation of DNA replication. In eukaryotes, the control of
DNA initiation requires the coordination of several proteins/
protein complexes (reviewed in Costa et al., 2013; Fragkos
et al., 2015). The origin recognition complex (ORC), a heterohex-
amerwith DNA-dependent ATPase activity, directly recognizes
and binds origins of replication. Subsequently, Cdc6 and Cdt1
are recruited to the origins and are able to load the minichro-
mosomemaintenance protein (MCM) complexMCM2e7, a het-
erohexamer that has ATPase-dependent DNA helicase activity,
onto the replication origin. The binding of the helicase to the
DNA starts the licensing of replication origins and forms the
so-called prereplicative complex (pre-RC). In this loading pro-
cess, ATP hydrolysis by Cdc6 helps the stable association of
MCM2-7 with the DNA, after which the interaction with two
additional factors enhance its helicase activity: the heterote-
trameric GINS complex (formed by Psf1, Psf2, Psf3 and Sld5 pro-
teins) and CDC45, forming the CMG complex. This complex is
subsequently activated by S phase CDKs and CDC7eDBF4.
Then, the replication protein A complex (RPA) binds to and sta-
bilizes the single-stranded DNA, interacts with the DNA poly-
merase-a-DNA primase complex (Pol a complex) and acts as
a “fidelity-clap” for the polymerase (Bochkareva et al., 1998;
Fanning et al., 2006; Maga et al., 2001). Polymerization by the
Pol a complex marks the start of DNA replication in the cell
that continueswith the recruitment of other DNA polymerases
and the help of associated factors.
Cdt1 is a major regulatory factor during the initiation of
DNA replication. Cdt1 is inhibited by Geminin, but regulation
of Cdt1 protein levels also critically depends on ubiquitin-
mediateddegradation by the proteasomeduring cell cycle pro-
gression (Saxena and Dutta, 2005). Cdt1 levels are high during
mitosis and G1 phase of cell cycle and low during S and G2
phases (Nishitani et al., 2001; Rialland et al., 2002;
Wohlschlegel et al., 2000). DNA origin licensing starts during
metaphase (Dimitrova et al., 1999), which coincides with
drop of Geminin levels that continue to be low during G1 and
rise again during S/G2 phases, thereby avoiding origin
licensing after G1 (Clijsters et al., 2013; McGarry and
Kirschner, 1998). Moreover, Cdt1 was shown to be degraded
in the presence of DNA damage as Cdt1 levels drastically
drop after a genotoxic insult (Higa et al., 2003; Hu et al., 2004).
Together these regulatory mechanisms help to restrict the
replication licensing to only once per cell cycle and/or avoid
DNA replication in the presence of damage.
Several E3 ligase complexes were described to target Cdt1
for proteasomal degradation in different conditions. Cdt1
degradation during the cell cycle was shown to depend onand on SCF-FBXO31 (Chandrasekaran et al., 2011; Higa et al.,
2006; Jin et al., 2006; Johansson et al., 2014; Nishitani et al.,
2006; Sansam et al., 2006). Moreover, CRL4-Cdt2 dependent
degradation of Cdt1 depends on DNA-bound PCNA, which oc-
curs during S phase and after DNA damage (Arias andWalter,
2006; Senga et al., 2006).
Although relatively much is known about the ubiquitina-
tion of Cdt1, the reverse process or Cdt1 deubiquitination is
less studied. In this article we find USP37 as a ubiquitin hydro-
lase for Cdt1. USP37 was first identified as key enzyme that
stabilizes Cyclin A counteracting the ubiquitination by the
anaphase-promoting complex APC/CCdh1 (Huang et al.,
2011). USP37 itself is a substrate of the APC/CCdh1 and its
regulated during the cell cycle as USP37 levels increase at
the G1/S boundary, and remain high during S and G2 phases
(Huang et al., 2011). USP37 is degraded at the G2/M boundary
in a SCF-b-TRCP and Plk1-dependent manner and remains
low in G1 phase of cell cycle (Burrows et al., 2012). Since its first
description in 2011, USP37 function has been linked to a num-
ber of different proteins. These include important pro-division
regulators (Cyclin A, c-Myc or 14-3-3g) but also USP37 is able to
regulate genomic stability by controlling DNA double strand
break repair by homologous recombination or proper mitotic
progression by controllingWAPL, a negative regulator of chro-
matin cohesion (Huang et al., 2011; Kim et al., 2015; Pan et al.,
2014; Typas et al., 2015; Yeh et al., 2015).
In this article we describe a new role of USP37 controlling
Cdt1 and DNA replication. USP37 overexpression increases
Cdt1 protein levels and knock down of this deubiquitinating
enzyme (DUB) leads to lower Cdt1 levels. Importantly, USP37
depletion impacts on the loading of the MCM2-7 replication
helicase and on the replication fork speed demonstrating its
critical role in regulating DNA replication.2. Materials and methods
2.1. Cell lines and plasmids
U2OS and 293T cells were grown using standard procedures.
The Addgene expression plasmid #22602 for Flag-HA-USP37
was obtained from JWHarper (HarvardMedical School, Boston,
USA) (Sowa et al., 2009). A catalytic inactive version of USP37
was obtained by changing the Cysteine 350 to Serine into the
Flag-HA-USP37 expressing plasmid, using the QuickChange
Site-Directed Mutagenesis Kit (Agilent Technologies). The
same kit was used to generate an siRNA#1 resistant version
of the Flag-HA-USP37 by introducing the following 4 silent mu-
tations (shown in lower case) in the cDNA: CAGCTgtcTCAcAA-
CATT. Cdt1 cDNAwas cloned into the pEXPR-IBA103 (Novagen)
vector to obtain a Strep-Cdt1 expressing plasmid. An expres-
sion plasmid for His-Ubiquitin was a gift from D. Bohmann
(Rochester, New York, USA) (Salghetti et al., 1999).
2.2. Cell synchronizations
Cells in G1 or mitosis were synchronized with a single thymi-
dine block (2.5 mM thymidine for 24 h) and release. Also to
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(Cayman) for 20 h. After 8 h, 0.1 mg/ml nocodazole (Sigma-
eAldrich) was added for 16 h. Mitotic cells were then isolated
by shake off and lysed (mitotic cells) or nocodazole was
washed off and cells were replated in fresh medium for 5 h
(G1 cells). For synchronization at G1/S, a single thymidine
block was used. To obtain S and G2 cells, thymidine was sub-
sequently washed off and cells were collected after 4 and 12 h,
respectively.2.3. Antibodies and reagents
Antibodies obtained from commercial sources were: anti-
b-actin (clone AC-15, SigmaeAldrich), anti-USP37
(ab190184), anti-Cdt1 (ab70829) and anti-Kap1 (ab190178)
antibodies from Abcam, anti-g-H2AX (Clone JBW301)
and anti-ubiquitinylated proteins (clone FK2, #04-263)
from Merck-Millipore, anti-Chk1 (G-4), anti-Cdt1 (H-300),
anti-RRM2 (N-8) and anti-GAPDH (FL-335) from Santa
Cruz Biotechnology, anti-pSer317-Chk1 from R&D, anti-
pSer10 histone H3 and anti-Flag from Genscript and anti-
RRM1 and mouse anti-Ubiquitin from Cell Signaling.
The anti-Cdt1 antibody was raised against amino acids
1e230 of human Cdt1. Anti-MCM7 and anti-Rad9 were
previously described (Mendez and Stillman, 2000; Toueille
et al., 2004).
Thymidine and nocodazole were purchased from Sigma
Aldrich and MG132 (used at 5 mM for 16 h or 6 h at 20 mM)
from Calbiochem. Lambda phosphatase was purchased from
New England Biolabs.2.4. Cell transfections
Transfections of plasmids were performed using stan-
dard calcium phosphate method (Perez-Castro and
Freire, 2012). For downregulation, siRNA oligos were
transfected using Lipofectamine RNAiMAX (Thermo
Fisher) according to the manufacturers instructions. The





Cdt1 AACGUGGAUGAAGUACCCGACdTdT2.5. Immunoprecipitations and ubiquitin assays
Immunoprecipitations were carried out with anti-Flag M2-
agarose (SigmaeAldrich) or with Cdt1/control antibody
crosslinked to protein A sepharose CL-4b (GE Healthcare)
as previously described (Perez-Castro and Freire, 2012).
His-Ubiquitin pull downs were carried out using Nickel-
NTA agarose (Qiagen) as described before (Mamely et al.,
2006).2.6. Chromatin fractionation
Biochemical fractionation of cells was performed as previ-
ously described (Mendez and Stillman, 2000; Smits et al., 2006).
2.7. Flow cytometry
Cells were collected by trypsinization and fixed in 70%
ethanol at 4 C for minimal 2 h. After fixation, cells were
washed with PBS and the DNA was stained with propidium
iodide. For BrdU staining, cells were incubated with BrdU
10 mM for 30 min. After fixation, cells were washed with
0.5% PBS-T (0.5% Tween-20 in PBS) and then incubated in
denaturing solution (0.5% Triton X-100, 2 M HCl) for 30 min
at 37 C. Then cells were neutralized with 1M TriseHCl pH
7.5. After washing with PBS, cells were incubated with anti-
BrdU antibody (GenScript) in BSA-T-PBS (1% BSA, 0.5% Tween
20 in PBS) for 16 h at 4 C. After washing with BSA-T-PBS,
cells were incubated with Alexa 647 secondary antibody
(Life Technologies) followed by staining with 25 mg/ml propi-
dium iodide. The samples were analyzed using a MACSQuant
Analyzer flow cytometer using MACSQuantify software (Mil-
tenyi Biotec).
2.8. DNA fiber analysis
Exponentially growing cells were pulse-labeled with 50 uM
CldU (20 min) followed by 250 uM IdU (20 min). Labeled cells
were collected and DNA fibers were spread in buffer contain-
ing 0.5% SDS, 200mMTris pH 7.4 and 50mM EDTA. For immu-
nodetection of labeled tracks, fibers were incubated with
primary antibodies (for CldU, rat anti-BrdU; for IdU, mouse
anti-BrdU) and developed with the corresponding secondary
antibodies conjugated to Alexa dyes. Mouse anti-ssDNA anti-
body was used to assess fiber integrity. Slides were examined
with a Leica DM6000 B microscope, as described previously
(Mouron et al., 2013). The conversion factor used was
1 mm ¼ 2.59 kb (Jackson and Pombo, 1998). In each assay, at
least 200 tracks were measured to estimate fork rate and
around 300 tracks were analyzed to estimate the frequency
of origin firing (first label origins e greeneredegreen e are
shown as percentage of all red e CldU e labeled tracks)
(Petermann et al., 2010).
2.9. Quantitative real-time RT-PCR
Total RNA was isolated from cells by the Chomczynski
method (Chomczynski and Sacchi, 1987). The purity and con-
centration of RNA was determined by Nano-drop 2000
(Thermo-Fisher). The quantification of relative abundance of
Cdt1 mRNA was carried out using quantitative PCR and the
SYBR green detection method. Total RNA was reverse tran-
scribed using a cDNA synthesis kit (Promega, Madison, WI),
following the manufacturers instructions, and the Cdt1
cDNA was PCR amplified using gene-specific primers. The ol-
igonucleotides used were: 50 TAATCTGACCTCCTGGTGCC
30 (forward primer), and 50 GTAGGCGTTTTGAGGAGTGC 30
(reverse primer). The resulting increase in fluorescence during
the PCR reaction was detected in the iQ5 system (Bio-Rad,
M O L E C U L A R O N C O L O G Y 1 0 ( 2 0 1 6 ) 1 1 9 6e1 2 0 6 1199Hercules, CA) and gene expression was normalized with the
reference gen GADP. The data were analyzed using 2 (-Delta
Delta C(T)) Method (Livak and Schmittgen, 2001).3. Results and discussion
3.1. USP37 regulates Cdt1 protein levels
Cdt1 levels are regulated by ubiquitin-dependent proteaso-
mal degradation during the cell cycle and after DNA damage.
Since so far no enzymes were described to regulate Cdt1 deu-
biquitination, we carried out an overexpression screen with
a library of human ubiquitin and ubiquitin-like hydrolases.
We first raised an anti-Cdt1 antibody and the specificity of
this antibody was checked using extracts of Cdt1 protein-
depleted cells and cells overexpressing a Flag-tagged version
of Cdt1 (Supplemental Figure 1A and B). The antibody recog-
nized a specific signal both in 293T and U2OS cells. The
screen was then carried out with a collection of 78 different
hydrolases, mainly ubiquitin hydrolases but also Sumo hy-
drolases in both control conditions and after DNA damage
(30 min after UV light) and Cdt1 protein levels were studied
by Western blot. We expected the overexpressed hydrolase
enzyme targeting Cdt1 to decrease ubiquitination and there-
fore to increase Cdt1 protein levels. The result of the full
screen is shown in Supplemental Figures 2 and 3. Surpris-
ingly, overexpression of only one DUB in our library,
USP37, was able to increase levels of Cdt1 (Supplemental
Figure 3 and Figure 1A). The effect of Cdt1 upregulation after
USP37 overexpression was observed under conditions of
DNA damage. In unperturbed cells, Cdt1 expression levels
similar to the control were observed for all deubiquitinases
tested. No significant changes in Cdt1 mRNA levels were
observed after USP37 overexpression, indicating that the in-
crease of Cdt1 was due to changes at protein level only
(Figure 1B). A more detailed study shows that levels of Cdt1
were upregulated after USP37 overexpression also basal con-
ditions and at different times after DNA damage (Figure 1C).
Since cell cycle progression could be affected by USP37 over-
expression and Cdt1 levels change during the cell cycle, the
experiment was repeated in cells synchronized in S phase.
Figure 1D shows an USP37-dependent stabilization of Cdt1
in cells with similar DNA profiles, excluding the possibility
of an indirect cell cycle effect. In this experiment also the
levels of the RRM1 and RRM2 subunits of the ribonucleotide
reductase and phosphorylated H2AX (gH2AX) were analyzed,
as changes in these proteins might be indicative of anoma-
lous S phase progression. However, no significant differ-
ences were found after USP37 overexpression (Figure 1D).
Moreover, USP37 overexpression did not affect cell cycle pro-
gression judged by BrdU/PI flow cytometry analysis
(Figure 1E). If the overexpression of USP37 increases Cdt1
protein levels by affecting its ubiquitination- and
proteasomal-dependent degradation, lack of USP37 should
have the opposite consequence. Depletion of USP37 by siRNA
indeed resulted in decreased Cdt1 protein levels in basal
conditions, as shown in Figure 1F. Nevertheless, the Cdt1
degradation kinetics after DNA damage is similar in Lucand USP37 siRNA treated cells, indicating that only the over-
expression of the USP37 can stabilize Cdt1 after DNA dam-
age. Also, overexpression of an siRNA resistant version of
Flag-USP37 rescued the drop in Cdt1 levels caused by
USP37 depletion (Supplemental Figure 4A).
Western blot analysis using the Cdt1 antibody showed
two Cdt1 bands in most of the experiments, of which pre-
dominantly the upper band becomes stabilized after USP37
overexpression. We therefore pursued to characterize the
nature of the upper band. Our antibody was raised against
the N-terminus of Cdt1. To explore if the upper band was
a Cdt1 splice variant, two other commercial antibodies
were used that recognize the Cdt1 C-terminus. As shown
in Figure 2A, the three antibodies detected both Cdt1 bands,
suggesting that the upper band is a modified version of Cdt1
rather than a splice form. Since USP37 catalytic activity
removes ubiquitin and Cdt1 is target for degradation by
the proteasome, we reasoned that the upper band might
be an unstable form of Cdt1. Indeed, addition of the protea-
some inhibitor MG132 increases the level of the band that
moves with lower mobility (Figure 2B) and interestingly,
USP37 knock down decreased the upper band under such
conditions indicating that even in the presence of MG132,
the lack of USP37 destabilizes the Cdt1 upper band. The
experiment was repeated with 3 different USP37 siRNA oli-
gos with a similar outcome, indicating that the observed
decrease in Cdt1 stability was due to USP37 depletion and
not the result of an off target effect (Figure 2C). Next, to
further investigate the nature of the unstable upper band,
the possibility of an (mono-)ubiquitin modification was
tested. For that, endogenous Cdt1 was immunoprecipitated
from USP37 overexpressing cells. Even though both forms
of Cdt1 were efficiently immunoprecipitated (Supplemental
Figure 4B and Figure 2D), no signal was observed after prob-
ing the immunoprecipitate with anti-ubiquitin or conju-
gated ubiquitin antibodies (Figure 2D). This result argues
against the Cdt1 slow mobility being the result of ubiquitina-
tion. Then the extracts were treated with lambda phospha-
tase, to examine possible phosphorylation of Cdt1. Rad9,
45 kDa in unphosphorylated form, but up to 60 kDa when
phosphorylated (St Onge et al., 2001, 1999; Volkmer and
Karnitz, 1999), was used as a positive control for lambda
phosphatase activity (Figure 2E). Treating the extracts with
phosphatase resulted in a reduction of the Cdt1 upper
band that is induced by USP37 overexpression (Figure 2E).
As an additional approach, Cdt1 was immunoprecipitated
from USP37 overexpressing cells and the purified immuno-
precipitates were treated with lambda phosphatase. Again
an increase of the low mobility band was observed after
USP37 overexpression. This band disappeared completely
after phosphatase treatment (Figure 2F). These experiments
strongly suggest that the Cdt1 mobility shift is due to phos-
phorylation. Instability of a low mobility, phosphorylated
form of Cdt1 was also described by others and an additional
study showed that this Cdt1 phosphorylation is dependent
on CDKs. This phosphorylated form of Cdt1 interacts with
the SCF-Skp2 complex that targets Cdt1 for ubiquitination
(Li et al., 2003; Liu et al., 2004). Therefore, is likely that
USP37 counteracts this ubiquitination and degradation by
binding with higher affinity.
Figure 1 e USP37 controls Cdt1 levels. (A) 293T cells were transfected with an empty vector (EV) or expression plasmids for the indicated DUBs
and when indicated treated with UV light (40 J/m2) and collected 30 min later. Cell lysates were analyzed by Western blot with the indicated
antibodies. (B) 293T cells transfected with EV or Flag-USP37 were lysed for analysis of mRNA levels by real-time PCR or by Western blot with
the indicated antibodies. The graph shows the average Cdt1 mRNA levels of 3 independent experiments. (C) 293T cells were transfected with EV
control or Flag-USP37. Then, cells were left untreated or treated with 40 J/m2 UV light before collecting them at the indicated times (min).
Extracts were analyzed by Western blot. (D) 293T cells transfected with Flag-USP37 were incubated with thymidine for 24 h and released in fresh
medium for 4 h. Then cells were left untreated or treated with UV light (40 J/m2) and collected 30 min post-treatment before Western blot (left) or
by flow cytometry (propidium iodide) analysis. (E) 293T cells were transfected with Flag-USP37 or empty vectors and were labeled with BrdU
(30 min) for FACS analysis. The percentage of BrdU positive cells is indicated. (F) U2OS cells were transfected with the indicated siRNA oligos
and left untreated or UV irradiated (40 J/m2) before collection at the indicated times and analysis by Western blot. Quantification of Cdt1 levels
compared to the loading control b-actin is shown at the bottom. In this quantification, Cdt1 levels in all samples were compared to those in siLuc
cells without damage (set as 1, upper row). Also, samples of USP37 depleted cells were compared to the undamaged control (set to 1, bottom row).
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Next, to examine if USP37 was directly affecting Cdt1 levels,
the interaction between the two proteins was analyzed by
immunoprecipitation. Endogenous Cdt1 co-immunoprecipi-
tated with overexpressed Flag-USP37 (Figure 3A). Although
overexpression of USP37 stabilizes Cdt1 after DNA damage,
Figure 3B shows that the interaction between the two proteins
did not significantly change under these conditions, suggest-
ing that Cdt1 stability after UV light is not due to changes in
affinity towards USP37. Interestingly, Cdt1 upper band isenriched in the immunoprecipitations, indicating USP37 regu-
lation preferentially over that isoform.
The interaction data suggest that USP37 directly affects
Cdt1 ubiquitination. We therefore tested if the ubiquitination
status of Cdt1 is affected by USP37 overexpression. As a con-
trol a catalytic inactive version of USP37 (Cys350Ser) was
used. After expression of His-Ubiquitin in 293T cells and per-
forming a pull down for His containing proteins, ubiquitinated
forms of Cdt1 were detected (Figure 3C, second lane). Ubiqui-
tinated forms of Cdt1 notably decreased upon co-expression
of wild type USP37. In contrast, Cdt1 ubiquitination increased
Figure 2 e USP37 stabilizes a phosphorylated form of Cdt1. (A) 293T cells transfected with empty or Flag-USP37 vector were lysed and loaded
three times in the same gel for parallel Western blot analysis with three different Cdt1 antibodies. The anti-Cdt1 immunoblot intensities were
different and comparable exposures in each case are shown. (B) 293T cells were transfected with control or USP37 siRNA oligos and left untreated
or treated with MG132 for 6 h when indicated. Cell lysates were analyzed with the indicated antibodies. (C) The same as (B), but using U2OS cells.
(D) Endogenous Cdt1 was immunoprecipitated with the anti-Cdt1 antibody from lysates of 293T cells overexpressing USP37. Input and
immunoprecipitates were analyzed by Western blot with the indicated antibodies. Two different exposures of the same blot are shown. (E) 293T
cells transfected with empty or Flag-USP37 overexpression vectors were lysed. Extracts were treated or not with lambda phosphatase for 60 min
prior analysis by Western blotting with the indicated antibodies. (F) 293T cells overexpressing Flag-HA-USP37 were lysed and anti-Cdt1
immunoprecipitations were carried out. The indicated immunoprecipitates were incubated with lambda phosphatase for 60 min before analysis by
Western blot with the indicated antibodies.
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pression of the catalytic inactive protein antagonizes the
endogenous wild type USP37. Altogether these data strongly
indicate that Cdt1 is a target substrate for USP37.
3.3. USP37 regulates Cdt1 during G1 and G1/S
To understand the biological significance of the Cdt1 regulation
by USP37, first the levels of both proteins during the cell cycle
were examined. It is documented that during the cell cycle,
both proteins are controlled by ubiquitin-mediated proteaso-
mal degradation, but in a distinct way. While Cdt1 levels are
starting to raise during mitosis, continue high in G1 and
decrease in S and G2 phases, USP37 levels are low in G1 and in-
crease in S and G2 phases (Huang et al., 2011; Nishitani et al.,
2000). Figure 4A confirms that USP37 levels were mainly high
at the G1/S transition and in S and G2, in agreement to its
described role to promote S phase entry (Huang et al., 2011).
In contrast, Cdt1 protein levels were high in G1 and mitosisand low in S/G2 phases. Cdt1 damage-specific degradation
occurred during all stages of cell cycle except mitosis, similar
to recently reported (Morino et al., 2015). Interestingly, after
UV irradiation in S and G2 phases USP37 levels showed a slight
decrease and also a mobility shift, suggesting a DNA damage-
induced posttranslational modification specifically in these
phases. Importantly, USP37 proteinwas lowbut detectable dur-
ing the G1 phase and likewise, Cdt1 levels were low but detect-
able during S/G2 (Figure 4A). We therefore questioned during
what phase of cell cycle USP37 regulates Cdt1. Cells were syn-
chronized in different stages of the cell cycle and at the same
time USP37 was depleted by siRNA. Interestingly, knock down
of USP37 reduced the levels of Cdt1 in G1 and G1/S but not dur-
ing S phase, indicating that althoughUSP37 levels are low inG1,
this DUB still functions to stabilize Cdt1 at this moment of the
cell cycle (Figure 4B). USP37 depletion clearly affected the levels
of the lower Cdt1 band, whereas the upper band is not detected
here. This adds proof to our hypothesis that the upper phos-
phorylated band of Cdt1 is an unstable form of Cdt1.
Figure 3 e USP37 interacts with and deubiquitinates Cdt1. (A) 293T cells transfected with an empty vector or Flag-USP37 were lysed and
immunoprecipitations were carried out with anti-Flag beads. Immunoprecipitates were analyzed by Western blot with anti-Cdt1 and anti-USP37
antibodies. (B) As in (A), but when indicated, cells were UV irradiated (40 J/m2, 1 h). (C) 293T cells were transfected with a plasmid expressing
Strep-Cdt1 together with control or His-Ubiquitin expression plasmids, and wild type or catalytic inactive Flag-USP37. 20 h after transfection,
cells were incubated with MG132 for 16 h before lysis under denaturing conditions. Western blot analysis of input and His-pull downs were carried
out with the indicated antibodies.
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Since the role of USP37 was linked to the transition from G1 to
S phase, but not much was known about its role during DNAFigure 4 e USP37 controls Cdt1 levels during G1 and G1/S. (A) U2OS w
described in Materials and Methods. When indicated, 30 min before colle
collected for propidium iodide analysis by flow cytometry (right) or Wester
with control or USP37 siRNA oligos and synchronized at the same time as
the indicated antibodies (left) and another fraction of cells was collected foreplication, replication fork speed was measured accurately
by DNA fiber analysis. As shown in Figure 5A, replication
fork progression rate was significantly delayed in USP37-
depleted cells as compared to control cells and consequentlyere left asynchronous or synchronized using different protocols as
cting, cells were treated with 40 J/m2 UV light. Then samples were
n blot with the indicated antibodies (left). (B) U2OS were transfected
described. A fraction of cells was lysed for Western blot analysis with
r flow cytometry analysis after propidium iodide staining (right).
Figure 5 e USP37 controls replication fork speed and impacts on MCM loading. U2OS cells were left untreated or transfected with control or
USP37 siRNA oligos (A) or 293T were left untreated or transfected with an empty or Flag-USP37 expressing plasmid (B). 48 h after transfections
cells were labeled with nucleotide analogues as described in materials and methods. Cells were then collected for DNA fiber analysis, for Western
blotting with the indicated antibodies and for flow cytometry analysis (BrdU/PI). Depicted is the replication fork speed and the percentage of
origin firing from two different experiments. Horizontal lines represent the median of relative fork speed distribution. Western blots and flow
cytometry graphs are shown from a representative experiment. (C) 293T cells transfected with an empty vector or Flag-USP37 expressing plasmid
were synchronized by thymidine block and collected 4 h after thymidine release for flow cytometry analysis or for biochemical fractionation and
Western blot analysis with the indicated antibodies. S1 D S2 represent soluble proteins, P2 the chromatin fraction. Quantification of the MCM7
levels in the chromatin fraction compared to the levels of histone H3 is represented. In the first row the MCM7 levels are compared to EV without
damage, the second row compares L/D Flag-USP37 expression in UV-treated cells. (D) Model summarizing previously known data and the new
data from this article. USP37 deubiquitinates a phosphorylated, unstable form of Cdt1. USP37 also delays replication fork speed by a mechanism
likely independent of Cdt1.
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observed under these conditions. These data strongly suggest
that USP37 plays an active role in replication fork progression.
It is tempting to speculate that USP37 could stabilize one of the
important proteins at the replication fork, and since there was
no reduction of the percentage of replication origins firing,
this effect is unlikely to be due to controlling Cdt1 directly.
As shown in Figure 1D and E, this effect is also not the result
of a reduced availability of nucleotides by controlling the
levels of the subunits RRM1 or RRM2 of the ribonucleotide
reductase. As USP37 was described to control Cyclin A, known
regulator of DNA replication, this Cyclin is a candidate target
for the decrease on replication fork speed after USP37 deple-
tion (Huang et al., 2011).
However, USP37 overexpression did not lead to a signifi-
cant change in the replicative parameters compared to con-
trol conditions (Figure 5B). Nevertheless, we continued to
study the role of USP37 in modification of Cdt1 particularly,
and the effect of USP37 overexpression on the loading of
the MCM2-7 complex, the major function of Cdt1 in initiation
of DNA replication, was examined. To avoid any undesired
cell cycle effects, cells synchronized in early S phase were
used. Notably, USP37 overexpression increased MCM7
loading onto the insoluble nuclear fraction (P2; chromatin)
of the chromatin fractionation (Figure 5C). This effect was
also observed in UV-irradiated S phase cells (Figure 5C),
strongly suggesting that USP37 can regulate the initiation
of DNA replication. Similar experiments were performed af-
ter USP37 depletion, resulting in no changes on MCM7
loading, suggesting that the there is an excess of Cdt1 to
achieve the loading. Another possibility to explain the
uploading of MCM7 after USP37 overexpression is a direct
change in the ubiquitination status of MCM7 by USP37. How-
ever, in vivo ubiquitination experiments did not show
changes in MCM7 ubiquitination status after USP37 overex-
pression (Supplemental Figure 4C). Interestingly, similar to
others, an increase on the ubiquitination status of the
USP37 catalytic inactive version comparing to the wild type
UPS37 was observed, suggesting that USP37 could auto-de-
ubiquitinate (Tanno et al., 2014).
The fact that overexpression of USP37 did not change repli-
cation parameters (Figure 5B) or cell cycle profiles (Figures 1E
and 5B) in spite of increasing MCM7 loading suggest that the
other known mechanisms controlling Cdt1/initiation of repli-
cation are able to maintain replication levels normal after
even when Cdt1 protein is upregulated. Future work will
investigate this into detail. Similarly, the increase of MCM7
loading after UV treatment might not have an effect on repli-
cation parameters, as recently it was shown that a non-
degradable version of Cdt1 does not induce additional DNA
synthesis after DNA damage (Tsanov et al., 2014).
Altogether, we show that USP37 is a DUB that modifies
Cdt1, a central protein in DNA replication initiation, by stabi-
lizing mainly a low mobility form that is likely a phosphory-
lated form of Cdt1 (Figure 5D). Our data also demonstrate
that USP37 controls DNA replication fork speed (Figure 5D)
and it is expected that this effect on DNA fork speed is by con-
trolling different target proteins than Cdt1, as Cdt1 itself is not
predicted to have a major role in replication fork speed regu-
lation. This adds USP37 to USP7 and USP29, recentlydemonstrated by us and others, as other important DUBs in
DNA replication (Jagannathan et al., 2014; Martın et al., 2015).
Further studies are needed to establish the details of regu-
lation of USP37 itself, although our data indicate that this pro-
tein is actively controlling Cdt1 function during G1 and S
phases. It is possible that the USP37 mobility change after
UV light, shown in Figure 3, reflects changes in its regulation.
The fact that USP37 is involved in DNA replication, and partic-
ularly in the control of the protein levels of Cdt1, a potential
oncogenic protein, makes it a putative therapeutic target in
cancer treatment. USP37 was shown to also stabilize other
known oncogenes like c-Myc or Cyclin A, strengthening the
relevance of USP37 inhibition in cancer therapy (Huang
et al., 2011; Pan et al., 2014).3.5. Conclusions
We identified a new regulator of DNA replication: USP37.
USP37 stabilizes the licensing factor Cdt1 and also plays a
further role in the progression of DNA replication.
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